Heart failure & cardiomyopathies

Genotype is Associated with Left Ventricular Reverse Remodelling and Early Events in Recent-Onset Dilated Cardiomyopathy

ESC Heart FailPublished Prospective cohort study

Authors' conclusion

RODCM patients harbouring class 4-5 non-TTN VOIs are at higher risk of progressive heart failure and life-threatening ventricular arrhythmias.

Study context

Population
Czech patients with recent-onset dilated cardiomyopathy (symptom duration ≤6 months) undergoing genetic counselling and whole-exome sequencing (WES) (72 cardiomyopathy-related genes)
Participants
386 patients
Exposure
Class 4-5 variants of interest (VOIs) vs negative genetic testing
  • TTNtvn = 69
  • non-TTN VOIsn = 56
Outcome
All-cause death, heart transplantation or ventricular assist device implantation
Follow-up
Median 41 months

Main finding

As reported in the abstract

  • Class 4-5 non-TTN VOIs, but not TTNtv, an independent baseline predictor of the primary outcome
  • Class 4-5 VOIs in nuclear envelope genes an independent baseline predictor of the primary outcome

Observational data: associations, not effects.

Secondary outcomes

Ventricular arrhythmia event (secondary outcome)

Class 4-5 non-TTN VOIs an independent baseline predictor
Negative genetic testing strongly protective against life-threatening ventricular arrhythmias
Nuclear envelope gene VOIs an independent predictor at baseline and after 12 months
Cytoskeleton gene VOIs associated with increased risk after baseline assessment

Left ventricular reverse remodelling (LVRR) · 12 months

Class 4-5 non-TTN VOIs, but not TTNtv, heralded lower probability of 12-month LVRR
Positive family history of DCM alone related only to lower probability of LVRR at 12 months and final follow-up

Original publication

Genotype is Associated with Left Ventricular Reverse Remodelling and Early Events in Recent-Onset Dilated Cardiomyopathy. ESC Heart Fail. Published 11 August 2024. doi:10.1002/ehf2.15009

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.